Table: Daito -2019/20 group results

Daito Pharmaceutical

10/07/2020 07:00

Jul 10 (Reuters)- 
          Daito Pharamaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                May 31, 2020    May 31, 2019   May 31, 2021     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             44.99           41.13          47.50                 
                 (+9.4 pct)      (+3.2 pct)     (+5.6 pct)               
  Operating          5.36            4.55           4.95                 
                 (+17.8 pct)     (+9.3 pct)     (-7.6 pct)               
  Recurring          5.46            4.64           5.00                 
                 (+17.7 pct)     (+9.4 pct)     (-8.5 pct)               
  Net
  Net                3.94            3.51           3.40                 
                 (+12.3 pct)     (+15.5 pct)    (-13.8 pct)              
  EPS            309.66 yen      280.73 yen     252.96 yen               
  EPS Diluted    307.44 yen                                              
  Ann Div         46.00 yen       38.00 yen      46.00 yen               
  -Q2 Div         20.00 yen       18.00 yen      23.00 yen               
  -Q4 Div         26.00 yen       20.00 yen      23.00 yen               
  
  NOTE - Daito Pharamaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T